Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2‐positive metastatic gastric cancer
Crossref DOI link: https://doi.org/10.1186/s40880-018-0344-6
Published Online: 2018-12-18
Published Print: 2018-12
Update policy: https://doi.org/10.1002/crossmark_policy
Shen, Lin
Version of Record valid from 2018-12-18
Publication History
Received: 2018-12-06
Accepted: 2018-12-07
Published: 2018-12-18